Storage and deposition diseases

1. High-Yield Summary

• Musculoskeletal storage and deposition disorders comprise a heterogeneous spectrum of inborn errors of metabolism and acquired crystalopathies characterized by abnormal tissue accumulation of metabolic substrates (sphingolipids, mucopolysaccharides), microcrystalline mineral salts (monosodium urate, calcium pyrophosphate), transition metals (iron), or misfolded protein fibrils (amyloid).
• Orthopaedic manifestations represent primary presenting signs or severe late sequelae, including osteonecrosis (avascular necrosis of the femoral and humeral heads in Gaucher disease), premature destructive arthropathy (calcium pyrophosphate deposition disease, hemochromatosis, ochronosis), soft tissue compressive neuropathies (carpal tunnel syndrome secondary to transthyretin amyloid or tophaceous gout), and pathologic fragility fractures.
• Diagnostic differentiation relies on polarized light synovial fluid analysis (negatively birefringent needle crystals in gout; weakly positive birefringent rhomboid crystals in CPPD), targeted imaging (dual-energy CT for uric acid; radiographic chondrocalcinosis, Erlenmeyer flask deformity, or 2nd/3rd MCP hook osteophytes), and histopathological staining (apple-green birefringence with Congo red under polarized light for amyloid; Prussian blue for hemosiderin; crinkled tissue-paper macrophages in Gaucher disease).
• Systemic disease control is mandatory before elective surgical reconstruction; enzyme replacement therapy (ERT) or substrate reduction therapy (SRT) in Gaucher disease, treat-to-target urate-lowering therapy in gout, and therapeutic phlebotomy in hemochromatosis must be initiated to optimize bone density, correct cytopenias, and minimize perioperative morbidity.
• Total joint arthroplasty requires specialized planning for altered osseous architecture, compromised marrow quality, heightened intraoperative hemorrhage risk, atypical implant fit, and elevated prosthetic infection rates.

2. Anatomy

Neurovascular Danger Zones

Storage and deposition diseases frequently alter standard soft-tissue compliance and distort anatomical tissue planes. In amyloid tenosynovitis and chronic tophaceous gout of the hand and wrist, dense peritendinous infiltration obliterates the subsynovial gliding tissue within the carpal canal. The median nerve becomes tethered and compressed beneath the transverse carpal ligament; blunt external neurolysis carries an increased risk of traction or thermal injury to the recurrent thenar motor branch, which may follow a transligamentous or subligamentous course through amyloid infiltrates. In the hip and knee, profound synovial hypertrophy and capsular fibrosis encountered in ochronotic arthropathy and chronic pyrophosphate arthropathy tether the femoral and sciatic neurovascular bundles closer to the articular capsule, heightening the risk of iatrogenic laceration during extensive capsulotomies.

Internervous Planes and Surgical Exposures

Surgical exposure for joint reconstruction must utilize reliable internervous intervals to protect adjacent musculature and innervation. For total hip arthroplasty in osteonecrosis secondary to Gaucher disease, the direct anterior approach exploits the internervous plane between the femoral nerve (tensor fasciae latae) and superior gluteal nerve (rectus femoris), while the posterior approach utilizes the interval between the gluteus maximus (inferior gluteal nerve) and external rotators. In the knee, the standard medial parapatellar arthrotomy provides wide exposure necessary for thorough debridement of chalky crystalline deposits, hypertrophic pigmented synovium, and subchondral cysts typical of hemochromatosis and ochronosis.

Critical Osseous Landmarks and Marrow Compartments

Bone architecture in storage disorders exhibits significant structural abnormalities. In Gaucher disease, massive accumulation of lipid-laden macrophages within the reticuloendothelial spaces of the axial and appendicular skeleton disrupts normal endosteal bone remodeling. This causes ballooning of the distal femoral metaphysis with failure of physiologic tubulation, creating the pathognomonic “Erlenmeyer flask” deformity. The femoral canal becomes widened, the cortices markedly thinned, and standard femoral component sizing algorithms are compromised. In hemochromatosis, bony deposition produces characteristic squaring of the metacarpal heads with prominent hook-shaped osteophytes along the radial aspects of the second and third metacarpals.

3. Pathogenesis

Lysosomal Enzyme Deficiencies and Macrophage Engorgement

Gaucher disease represents the prototypic lysosomal storage disorder affecting the musculoskeletal system. It is an autosomal recessive condition caused by biallelic mutations in the GBA1 gene on chromosome 1q21, which encodes the lysosomal enzyme glucocerebrosidase (acid beta-glucosidase). Deficiency of this enzyme impairs the hydrolytic cleavage of glucosylceramide (glucocerebroside) into glucose and ceramide. Unmetabolized substrate progressively accumulates within the lysosomes of cells belonging to the monocyte-macrophage lineage. These engorged “Gaucher cells” exhibit a classic histopathological appearance with wrinkled, eccentric nuclei and striated, fibrillar cytoplasm resembling crumpled tissue paper. Gaucher cells infiltrate the bone marrow cavity, exerting direct mechanical compressive forces on the intramedullary sinusoidal microvasculature. Concurrently, Gaucher macrophages secrete a potent array of pro-inflammatory cytokines, including interleukin-1 beta (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and macrophage inflammatory proteins (MIP-1α and MIP-1β). This cytokine surge stimulates RANKL-mediated osteoclastogenesis while simultaneously suppressing osteoblastic activity, culminating in osteopenia, marrow necrosis, and severe ischemic osteonecrosis.

Crystal Nucleation and Inflammasome Activation

Microcrystalline arthropathies arise from the precipitation of mineral salts within synovial fluid and periarticular connective tissues. In gout, chronic hyperuricemia exceeding the physiologic saturation threshold of sodium urate in synovial fluid (approximately 6.8 mg/dL at 37 degrees Celsius) promotes crystallization into monosodium urate (MSU) monohydrate crystals. Nucleation is accelerated by lower temperature, decreased pH, and degraded extracellular matrix components. MSU crystals are phagocytosed by synovial monocytes and macrophages, triggering the assembly of the intracellular NLRP3 inflammasome complex. This cascade activates caspase-1, leading to the rapid cleavage and extracellular release of mature IL-1β. The resultant neutrophilic influx drives acute, agonizing synovitis, while chronic foreign-body granulomatous reactions yield erosive tophi that mechanically destroy cartilage and subchondral bone.

In calcium pyrophosphate deposition (CPPD) disease, extracellular inorganic pyrophosphate (ePPi) levels rise due to upregulated activity of the membrane transporter ANKH and ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). Elevated ePPi binds ambient calcium within articular cartilage and fibrocartilage, precipitating as rhomboid calcium pyrophosphate dihydrate (CPP) crystals. CPP crystals alter cartilage biomechanics, accelerate chondrocyte apoptosis, and incite acute inflammatory flares (pseudogout) via NLRP3 activation similar to MSU crystals.

Heavy Metal Deposition and Free Radical Cartilage Destruction

Hereditary hemochromatosis is characterized by loss-of-function mutations in the HFE gene (predominantly C282Y homozygosity), which disrupts hepcidin regulation and induces unrestricted intestinal iron absorption. Excess circulating iron saturates transferrin, resulting in non-transferrin-bound iron that deposits in synovial tissue, articular chondrocytes, and subchondral bone as hemosiderin. Ferrous iron catalyzes the Fenton reaction, producing cytotoxic hydroxyl free radicals that induce lipid peroxidation of chondrocyte membranes, inhibit synovial hyaluronan production, and directly impair cartilage repair mechanisms. Iron also directly inhibits pyrophosphatase activity, explaining the frequent coexistence of chondrocalcinosis and pyrophosphate arthropathy in hemochromatotic joints.

Protein Misfolding and Amyloid Fibrillogenesis

Amyloidosis involves the extracellular deposition of abnormal protein fibrils organized in beta-pleated sheets. In wild-type transthyretin amyloidosis (ATTRwt), tetrameric transthyretin synthesized by the liver dissociates into unstable monomers that misfold and aggregate into amyloid fibrils. These fibrils exhibit a high tropism for collagen-rich musculoskeletal structures, including the transverse carpal ligament, flexor tenosynovium, ligamentum flavum, and rotator cuff tendons. Deposition causes physical tissue expansion, increased compartmental pressure, and progressive ischemic compressive neuropathy. In long-term hemodialysis patients, inadequate clearance of beta-2 microglobulin yields dialysis-related amyloidosis (DRA), which deposits in periarticular bone and synovium, forming expansile amyloid bone cysts and destructive spondyloarthropathy.

Alkaptonuria (ochronosis) is caused by a congenital deficiency of homogentisate 1,2-dioxygenase, leading to the systemic accumulation of homogentisic acid (HGA). HGA oxidizes to benzoquinone acetic acid, which polymerizes into an insoluble black-brown pigment that binds irreversibly to type II collagen fibers. Pigment binding stiffens the extracellular matrix, cross-links collagen, and renders articular cartilage brittle, leading to rapid, catastrophic joint surface disintegration under physiologic loading.

4. Natural History

Epidemiology and Genetic Predisposition

The epidemiological distribution of storage and deposition diseases varies substantially across conditions:

• Gaucher Disease: Autosomal recessive inheritance. Type 1 (non-neuropathic) accounts for over 90% of cases in Western populations, with a carrier frequency as high as 1 in 15 among Ashkenazi Jewish individuals and a disease incidence of 1 in 850 in this population, compared to 1 in 50,000 in the general population.
• Microcrystalline Diseases (Gout & CPPD): Gout is the most prevalent inflammatory arthritis worldwide, affecting approximately 3.9% of US adults, with a pronounced male predominance (3:1 to 4:1) and peak incidence in the fifth to sixth decades. CPPD prevalence correlates strongly with aging, exceeding 10% in individuals older than 60 years and over 30% in those older than 80 years.
• Hereditary Hemochromatosis: Most common genetic disorder in Northern European populations (1 in 200 to 1 in 300 are C282Y homozygotes), but clinical arthropathy exhibits variable penetrance, manifesting in 25% to 50% of affected individuals typically after age 40.
• Amyloidosis: ATTRwt amyloidosis predominantly affects men over 60 years of age. Subclinical tenosynovial deposition is remarkably prevalent, detected in up to 10% of elderly patients undergoing surgical decompression for idiopathic carpal tunnel syndrome.
• Alkaptonuria: Rare autosomal recessive metabolic defect with a worldwide incidence of approximately 1 in 250,000 to 1 in 1,000,000 live births, with geographical clusters in Slovakia and the Dominican Republic.

Disease Progression and Long-Term Skeletal Sequelae

Untreated storage and deposition diseases follow progressive, disabling trajectories. In Gaucher disease, marrow infiltration leads to recurrent acute “bone crises” characterized by excruciating pain, fever, and leukocytosis mimicking acute osteomyelitis. Progressive marrow ischemia culminates in avascular necrosis of the femoral head in up to 30% of untreated patients, resulting in subchondral collapse, severe secondary osteoarthritis, and limb length discrepancy. In CPPD and hemochromatosis, relentless cartilage calcification and free-radical damage induce progressive joint narrowing, subchondral sclerosis, and exuberant osteophytosis resembling aggressive osteoarthritis. In ATTR amyloidosis, musculoskeletal involvement precedes life-threatening restrictive cardiomyopathy and conduction disease by 5 to 10 years, highlighting the critical role of the orthopaedic surgeon in early systemic detection.

5. Clinical Presentation

History

Clinicians must maintain high index of suspicion when evaluating patients with atypical, rapidly progressive, or multi-joint complaints. Key historical inquiries include:

• Episodic Severe Joint Pain: Abrupt onset of monoarticular or oligoarticular pain reaching maximal intensity within 6 to 24 hours, often waking the patient from sleep (characteristic of acute gouty arthritis or pseudogout).
• Deep Bone Pain and Skeletal Crises: Severe, deep-seated aching in the thighs, knees, or lower back, especially when accompanied by childhood bone pain, splenomegaly, or personal/family history of early hip collapse (Gaucher disease).
• Hand Stiffness and Early Grip Fatigue: Chronic stiffness, loss of dexterity, and ache localized to the 2nd and 3rd metacarpophalangeal joints, often with dark skin pigmentation, chronic fatigue, or diabetes mellitus (“bronze diabetes” in hemochromatosis).
• Bilateral Neuropathies and Soft Tissue Ruptures: Progressive numbness and tingling in the median nerve distribution, history of bilateral carpal tunnel releases, multiple trigger digits, spontaneous biceps tendon rupture, or symptoms of neurogenic claudication in an older male (ATTRwt amyloidosis).
• Urine Color Changes and Pigmentation: Darkening of urine upon standing, dark pigment deposits in the sclera or ear cartilage (ochronotic pigmentation in alkaptonuria).

Physical Exam

Physical examination must systematically evaluate the axial skeleton, peripheral joints, and soft tissue compartments. Specific provocative maneuvers and clinical findings demonstrate high diagnostic utility:

6. Imaging and Diagnostic Studies

Plain Radiography and Characteristic Deformities

Standard radiography serves as the primary diagnostic imaging tier. Specific radiographic features distinguish individual deposition entities:

• Gaucher Disease: Distal femoral metadiaphyseal flaring with loss of normal concavity (“Erlenmeyer flask deformity”), extensive patchy osteopenia, endosteal scalloping, medullary bone infarcts, and progressive subchondral collapse of the femoral or humeral head.
• CPPD Disease: Chondrocalcinosis appearing as linear, punctate radiodense deposits within hyaline articular cartilage and fibrocartilage. Hallmark sites include the knee menisci, triangular fibrocartilage complex (TFCC) of the wrist, and pubic symphysis. Advanced pyrophosphate arthropathy exhibits joint space narrowing, pronounced subchondral cyst formation, and sclerosis mimicking osteoarthritis but with disproportionate involvement of the patellofemoral and radiocarpal joints.
• Gout: Well-defined, “punched-out” subchondral and juxta-articular bony erosions with sclerotic margins and overhanging bony edges (Martel’s sign). Joint space is characteristically preserved until late-stage destructive disease. Tophi may present as asymmetric, dense periarticular soft tissue masses without primary calcification.
• Hereditary Hemochromatosis: Symmetrical joint space narrowing, subchondral sclerosis, and cyst formation predominantly at the 2nd and 3rd MCP joints. Pathognomonic “beak-like” or hook-shaped osteophytes originate from the radial aspect of the metacarpal heads. Chondrocalcinosis is visible in 30% to 50% of cases.
• Alkaptonuria (Ochronosis): Universal, dense wafer-like calcification of multiple intervertebral discs with dramatic disc space narrowing and prominent vacuum phenomena throughout the lumbar and thoracic spine. Large peripheral joints exhibit rapid joint space loss with minimal osteophyte formation.

Advanced Imaging: MRI, DECT, and Nuclear Scintigraphy

Cross-sectional and molecular imaging modalities provide essential diagnostic resolution:

• Magnetic Resonance Imaging (MRI): Gold standard for evaluating marrow replacement and early avascular necrosis. In Gaucher disease, lipid-laden macrophage marrow infiltration produces homogeneous low signal intensity on both T1- and T2-weighted sequences, displacing normal hyperintense fatty marrow. Validated scoring systems, such as the Bone Marrow Burden (BMB) score, quantify marrow clearance in response to enzyme therapy. In dialysis-related amyloidosis, expansile subchondral amyloidomas appear as low-to-intermediate signal on T1 and T2 images without significant enhancement.
• Dual-Energy Computed Tomography (DECT): Employs two distinct X-ray energy spectra (80 kVp and 140 kVp) to exploit the unique photoelectric absorption profiles of different chemical compositions. DECT demonstrates exceptional diagnostic sensitivity (85%–90%) and specificity (95%–98%) for color-coding monosodium urate crystal deposits in peripheral joints and tendons, distinguishing them from calcium hydroxyapatite.
• Technetium-99m Pyrophosphate (99mTc-PYP) Scintigraphy: Highly sensitive and specific for detecting cardiac ATTR amyloidosis. In patients presenting with bilateral carpal tunnel syndrome and suspicious red flags, cardiac scintigraphy offers non-invasive diagnostic confirmation without requiring endomyocardial biopsy.

Laboratory and Synovial Fluid Analysis

Arthrocentesis with polarized light microscopy is the definitive gold standard for crystal-induced arthropathies:

• Monosodium Urate: Needle-shaped, strongly negatively birefringent crystals. Under a red compensator, crystals aligned parallel to the slow axis turn bright yellow, whereas perpendicular crystals turn blue.
• Calcium Pyrophosphate: Rhomboid or rod-shaped, weakly positively birefringent crystals. Crystals aligned parallel to the slow axis turn blue.
• Gaucher Enzymatic & Biomarker Assay: Marked deficiency of acid beta-glucosidase activity in peripheral blood leukocytes (less than 15% of mean normal activity). Elevated plasma glucosylsphingosine (lyso-Gb1) serves as a sensitive, real-time biomarker for disease monitoring.
• Iron Panel & Genetic Testing: Transferrin saturation exceeding 45% and serum ferritin levels above 300 ng/mL in men (above 200 ng/mL in women) prompt targeted HFE genetic mutation testing (C282Y, H63D).
• Tissue Biopsy for Amyloid: Tenosynovial specimens stained with Congo red demonstrate salmon-pink staining under light microscopy and characteristic pathognomonic apple-green birefringence when viewed under cross-polarized light.

7. Classification

Storage and deposition diseases are categorized according to the underlying molecular defect, biochemical substrate, and clinical manifestation. The table below delineates the major musculoskeletal entities, validated classification frameworks, and their direct surgical implications:

8. Treatment

Medical / Nonoperative Management

Medical management aims to reverse substrate accumulation, control acute inflammation, and halt end-organ skeletal damage:

• Enzyme Replacement & Substrate Reduction in Gaucher Disease: Intravenous enzyme replacement therapy (ERT; imiglucerase, velaglucerase alfa) administered biweekly represents the gold standard. ERT reverses hepatosplenomegaly, resolves thrombocytopenia, alleviates bone pain, and reduces bone crises. Oral substrate reduction therapy (SRT; eliglustat, miglustat) acts as an alternative by inhibiting glucosylceramide synthase. Bisphosphonates or denosumab are adjunctively indicated for secondary osteopenia and osteoporosis.
• Treat-to-Target Management in Gout: Acute gout flares are managed with oral colchicine (1.2 mg followed by 0.6 mg one hour later), nonsteroidal anti-inflammatory drugs (NSAIDs), or systemic corticosteroids. Long-term urate-lowering therapy (ULT) with allopurinol (titrated up to 800 mg/day with renal monitoring) or febuxostat is indicated for patients with tophi, radiographic damage, or recurrent flares (two or more per year), targeting serum urate below 6.0 mg/dL (below 5.0 mg/dL in tophaceous disease). Anti-inflammatory prophylaxis (low-dose colchicine 0.6 mg daily) is maintained during the first 3 to 6 months of ULT.
• CPPD Prophylaxis and Symptom Control: Acute CPPD flares respond to intra-articular corticosteroid injections, oral NSAIDs, or low-dose colchicine. Chronic CPPD arthropathy is managed symptomatically with joint unloading, physical therapy, and anti-inflammatory agents. No approved disease-modifying therapy currently dissolves intra-articular CPP crystals.
• Therapeutic Phlebotomy in Hemochromatosis: Weekly phlebotomy is performed to deplete systemic iron stores until serum ferritin reaches 50 to 100 ng/mL. While life-saving for hepatic and cardiac function, phlebotomy rarely reverses established joint destruction; symptomatic management mirrors conventional osteoarthritis.
• Transthyretin Stabilizers in Amyloidosis: Confirmation of ATTR amyloidosis warrants cardiology referral for initiation of transthyretin tetramer kinetic stabilizers (tafamidis) or gene-silencing RNA therapeutics (patisiran, vutrisiran) that arrest ongoing amyloid fibril formation.

Operative Treatment

Surgical intervention addresses mechanical joint destruction, pathologic fractures, and compressive neuropathies:

• Core Decompression for Early Osteonecrosis: Indicated in pre-collapse stages (Ficat-Arlet stage I or II) of femoral head osteonecrosis in Gaucher disease. Multiple small-diameter drillings reduce intramedullary pressure, relieve bone pain, and promote revascularization, potentially postponing total hip arthroplasty.
• Total Joint Arthroplasty: The definitive treatment for collapsed osteonecrosis and advanced secondary osteoarthritis across Gaucher disease, CPPD, hemochromatosis, and ochronosis. In Gaucher patients, contemporary uncemented, highly porous titanium or tantalum acetabular and femoral components demonstrate superior survivorship compared to historical cemented designs, which suffered high rates of aseptic loosening. Intraoperative hemorrhage can be substantial due to vascular marrow engorgement and underlying coagulopathies; tranexamic acid and cell salvage are strongly recommended. In ochronosis and CPPD, extensive synovectomy and removal of brittle degenerate debris precede standard prosthetic implantation.
• Carpal Tunnel Decompression and Tenosynovial Biopsy: Standard open carpal tunnel release is indicated for progressive median nerve compression. In patients aged 50 years and older, routine tenosynovial debridement with tenosynovial biopsy for Congo red histology is critical for early diagnosis of ATTR amyloidosis.
• Tophectomy and Tenosynovectomy in Gout: Surgical excision of debilitating tophi is reserved for cases causing severe skin ulceration, secondary infection, recurrent sinus tracts, intractable nerve compression, or mechanical joint locking. Meticulous wound closure is imperative to avoid delayed breakdown over residual tophaceous debris.

Indications & Contraindications

Surgical decision-making relies on strict objective thresholds:

• Arthroplasty Indications: Progressive joint space loss, intractable pain unresponsive to multimodal nonoperative management, and post-collapse osteonecrosis (femoral head depression > 2 mm).
• Carpal Tunnel Release Indications: Persistent paresthesias, thenar motor weakness, or electrodiagnostic evidence of median neuropathy failing 6 to 12 weeks of conservative splinting and steroid injection.
• Absolute Contraindications: Active local joint or systemic sepsis; uncontrolled coagulopathy or profound thrombocytopenia (platelets < 50,000/mcL in Gaucher disease); unstable medical conditions (decompensated ATTR cardiomyopathy, end-stage hepatic cirrhosis).
• Relative Contraindications: Active, untreated acute gouty flare (relative contraindication for elective arthroplasty; wait 2 to 4 weeks after flare resolution); unoptimized serum urate > 8 mg/dL with extensive ulcerating tophi adjacent to proposed incisions.

9. Outcome

Modern reconstructive outcomes have dramatically improved with the advent of targeted medical therapies and advanced implant metallurgy:

• Arthroplasty Survivorship in Gaucher Disease: Early registry cohorts from the 1980s and 1990s using cemented femoral stems reported alarming 10-year revision rates of 30% to 50% due to aseptic loosening in dysplastic, lipid-filled bone. In contrast, modern cohorts utilizing uncemented, highly porous coated femoral and acetabular components in conjunction with continuous ERT demonstrate 10-year prosthetic survivorship exceeding 90% to 95%, with significant improvements in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and Harris Hip Scores.
• Functional Outcomes in Microcrystalline Arthropathy: Total knee and hip arthroplasty in patients with advanced CPPD disease and hemochromatosis yield functional improvements equivalent to those seen in primary osteoarthritis, with significant gains in Knee Society Scores (KSS) and Oxford Hip Scores. However, patients with hemochromatosis experience slightly higher rates of persistent periarticular stiffness and contracture.
• Carpal Tunnel Release in Amyloidosis: Open decompression achieves predictable pain relief and sensory improvement in over 85% of patients with tenosynovial amyloidosis. However, nerve recovery may be delayed or incomplete in the presence of severe pre-existing axonal neuropathy from transthyretin microangiopathy.

10. Complications

Complications across storage and deposition diseases are categorized by chronological onset, emphasizing distinctive pathophysiological risks:

11. Pearls and Pitfalls

• The Biopsy Imperative in Older CTS Patients: Whenever performing carpal tunnel release in men over 50 or women over 60, especially with bilateral symptoms or history of trigger digits, routinely send tenosynovial specimens for Congo red staining. Identifying ATTR amyloid in the wrist provides a 5 to 10 year window to institute life-saving cardiac therapy before irreversible heart failure develops.
• Avoid Misdiagnosing Gaucher Bone Crises as Osteomyelitis: Acute Gaucher bone crises present with excruciating localized bone pain, swelling, fever, leukocytosis, and elevated ESR/CRP, closely mimicking acute bacterial osteomyelitis. Routine surgical incision and drainage of a sterile bone crisis introduces a high risk of catastrophic secondary chronic bacterial osteomyelitis; conservative analgesia, hydration, and ERT adjustment are standard.
• Maintain Urate-Lowering Therapy Perioperatively: Never abruptly start or stop allopurinol or febuxostat during the acute perioperative period. Rapid fluctuations in serum urate destabilize established microcrystalline deposits, precipitating acute polyarticular gout flares. Continue baseline ULT without interruption and administer low-dose colchicine prophylaxis.
• Anticipate the “Erlenmeyer Flask” Canal Geometry: Standard straight or tapered wedge femoral stems may fit poorly within the expanded, cylindrical metaphyseal envelope of a Gaucher femur. Have modular, fully porous-coated cylindrical stems and calcar-replacing designs available in the operating room.
• Recognize Hemochromatosis MCP “Hook” Osteophytes: Symptomatic MCP arthropathy with prominent radial hook-like osteophytes and squaring of the metacarpal heads on plain hand radiographs is virtually pathognomonic for hemochromatosis. Screen immediately with serum ferritin and transferrin saturation before assuming routine degenerative disease.

12. Controversy

Several clinical and surgical controversies remain actively debated in the management of storage and deposition diseases:

• Universal vs. Risk-Stratified Tenosynovial Biopsy during Carpal Tunnel Release: While prospective investigations demonstrate that 8% to 10% of older adults undergoing carpal tunnel release harbor occult wild-type transthyretin amyloidosis, debate persists regarding the cost-effectiveness of universal histopathological screening. Proponents argue that the morbidity and expense of missed systemic amyloidosis far outweigh the marginal cost of Congo red staining. Opponents favor risk-stratified screening limited to patients with bilateral disease, concurrent trigger digits, hypertrophic ligamentum flavum, or elevated NT-proBNP.
• Timing of Joint Arthroplasty Relative to Enzyme Replacement Therapy in Gaucher Disease: Orthopaedic consensus mandates a minimum duration of preoperative ERT before elective total joint reconstruction to restore platelet counts, reduce marrow infiltration, and improve bone mineral density. However, the exact duration of preoperative medical optimization remains debated, ranging from 6 months in mild disease to 24 months in patients with profound marrow infiltration (high BMB scores) and severe osteopenia.
• Prophylactic Medical Dissolution vs. Surgical Excision of Tophaceous Gout: With the availability of intensive urate-lowering regimens, including the pegylated recombinant uricase pegloticase, profound debulking of massive subcutaneous and periarticular tophi can be achieved medically over 6 to 12 months. Whether surgical excision of complex tophi offers superior functional recovery or merely increases the risk of chronic sinus tract formation and wound breakdown remains a source of ongoing surgical contention.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Abhishek A, Tedeschi SK, Pascart T et al. The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease. Arthritis Rheumatol. 2023. doi:10.1002/art.42619 [Level II: International Multicenter Validation Study]
• FitzGerald JD, Dalbeth N, Mikuls T et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020. doi:10.1002/acr.24180 [Level I: GRADE Systematic Review & Practice Guideline]
• Weinreb NJ, Charrow J, Andersson HC et al. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med. 2002. doi:10.1016/s0002-9343(02)01150-6 [Level IV: Prospective International Registry Cohort]
• Kiely PD, Finzel S, Farisogullari B et al. EULAR 2025 classification criteria for haemochromatosis arthropathy. Ann Rheum Dis. 2026. doi:10.1016/j.ard.2025.10.003 [Level II: Multicenter Case-Control Validation Study]
• Donnelly JP, Hanna M, Sperry BW et al. Carpal Tunnel Syndrome: A Potential Early, Red-Flag Sign of Amyloidosis. J Hand Surg Am. 2025. doi:10.1016/j.jhsa.2025.07.017 [Level IV: Clinical Cohort & Systematic Review]

15. Master Class Pro-Tip

When undertaking total hip arthroplasty in patients with Gaucher disease or advanced ochronosis, preoperative templating must account for distorted metaphyseal anatomy and thinned cortices. In Gaucher disease, the widened metaphysis lacks normal endosteal press-fit geometry, creating a deceptive mismatch where standard tapered wedge stems achieve inadequate rotational stability. Always maintain a low threshold to utilize a modular tapered fluted stem or a porous-coated cylindrical stem that achieves reliable diaphyseal scratch-fit beyond the Erlenmeyer deformity. Prior to femoral broaching, place a prophylactic cerclage wire around the proximal femoral neck and trochanteric junction to prevent catastrophic cortical burst fractures in brittle, osteopenic bone. Concurrently, obtain strict preoperative hematologic clearance, administer intravenous tranexamic acid, and employ cell salvage to manage the profuse intramedullary bleeding characteristic of active marrow infiltration.

Master Class Surgical Pearl: Musculoskeletal Storage and Deposition Diseases